Treatment of people at ultra-high risk for psychosis

World Psychiatry

Volumn 16, Issue 2, 2017, Pages 207-208

  Yung, Alison R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; GLYCINE; LITHIUM SALT; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID;

COGNITIVE BEHAVIORAL THERAPY; COGNITIVE REMEDIATION THERAPY; FAMILY THERAPY; HIGH RISK POPULATION; HUMAN; META ANALYSIS (TOPIC); NOTE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SOCIAL COMPETENCE; ULTRA HIGH RISK POPULATION;

EID: 85019208801     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20424     Document Type: Note

References (10)

1. Yung A, McGorry PD, McFarlane CA et al. Schizophr Bull 1996;22:283-303.
2. Fusar-Poli P, Bonoldi I, Yung AR et al. Arch Gen Psychiatry 2012;69:220-9.
3. van der Gaag M, Smit F, Bechdolf A et al. Schizophr Res 2013;149:56-62.
4. Valmaggia L, Byrne M, Day F et al. Br J Psychiatry 2015;207:130-4.
5. Berger GE, Wood SJ, Ross M et al. Curr Pharm Des 2012;18:570-5.
6. Woods SW, Walsh B, Hawkins K et al. Eur Neuropsychopharmacol 2013;23:931-40.
7. McAusland L, Addington J. Early Interv Psychiatry (in press).
8. Choi J, Corcoran CM, Fiszdon JM et al. Psychiatr Rehabil J 2017;40:33-42.
9. O'Brien MP, Gordon JL, Bearden CE et al. Schizophr Res 2006;81:269-75.
10. Cotter J, Yung AR, Carney R et al. Behav Res Ther 2017;90:25-31.